Mérieux Equity Partners logo

Mérieux Equity Partners

Europe, Rhone-Alpes, France, Lyon

Description

Mérieux Equity Partners is a global investment platform specialized in the healthcare & nutrition sector.

Investor Profile

Mérieux Equity Partners has made 41 investments, with 2 in the past 12 months and 39% as lead.

Stage Focus

  • Series A (24%)
  • Series C (22%)
  • Series B (20%)
  • Series Unknown (15%)
  • Private Equity (10%)
  • Series D (7%)
  • Seed (2%)

Country Focus

  • France (37%)
  • United States (37%)
  • Belgium (7%)
  • Switzerland (5%)
  • United Kingdom (5%)
  • Israel (2%)
  • Finland (2%)
  • Canada (2%)
  • Sweden (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Medical
  • Medical Device
  • Therapeutics
  • Manufacturing
  • Pharmaceutical
  • Clinical Trials
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mérieux Equity Partners frequently co-invest with?

Supernova Invest
Europe, Ile-de-France, France, Paris
Co-Investments: 3
Shire
Europe, Dublin, Ireland, Dublin
Co-Investments: 4
IRDI
Europe, Midi-Pyrenees, France, Toulouse
Co-Investments: 2
GoldenArc Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Paladin Capital Group
North America, District of Columbia, United States, Washington
Co-Investments: 5
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 3
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 4
Sham
Europe, Rhone-Alpes, France, Lyon
Co-Investments: 2
+ND Capital
North America, California, United States, San Mateo
Co-Investments: 5
Venrock
North America, California, United States, Palo Alto
Co-Investments: 3

Which angels does Mérieux Equity Partners often collaborate with?

AV
Europe, Southern Finland, Finland, Helsinki
Shared Deals: 1
KS
North America, California, United States, San Francisco
Shared Deals: 1
BN
North America, Massachusetts, United States, Boston
Shared Deals: 1
EU
Europe, Istanbul, Turkey, Istanbul
Shared Deals: 1
JE
North America, California, United States, San Francisco
Shared Deals: 1
KB
North America, New York, United States, New York
Shared Deals: 1
FB
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Mérieux Equity Partners?

Ceva Santé Animale

Libourne, Aquitaine, France

Ceva Sante Animale is a veterinary health company focused on the research, development, production and marketing of pharmaceutical products.

Animal FeedBiotechnologyCannabisClinical TrialsPharmaceuticalVeterinary
Private EquityMar 31, 2025
CorFlow Therapeutics

Baar, Zug, Switzerland

CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions.

BiotechnologyManufacturingMedicalMedical Device
Series BSep 10, 2024
Amount Raised: $48,489,444
Prothea Technologies

Edinburgh, Edinburgh, City of, United Kingdom

Prothea Technologies is a private medical technology business to provide lung cancer biopsy and therapy in a single hospital visit.

HospitalMedicalWellness
Series AApr 9, 2024
Amount Raised: $13,030,674
Amyl Therapeutics

Liège, Liege, Belgium

Amyl Therapeutics is a preclinical stage biotechnology company.

BiotechnologyHealth CareLife ScienceMedical
Series ANov 7, 2023
Amount Raised: $5,669,225
Broken String Biosciences

Cambridge, Cambridgeshire, United Kingdom

Broken String Biosciences is developing a platform of novel sequencing tools to assess genome stability and to unlock the next generation.

BiotechnologyHealth Care
Series ASep 18, 2023
Amount Raised: $15,000,000
TISSIUM

Paris, Ile-de-France, France

TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.

BiotechnologyHealth CareMedical Device
Series DMay 23, 2023
Amount Raised: $53,847,396
Mablink Bioscience

Lyon, Rhone-Alpes, France

Mablink Bioscience is a biotechnology company.

BiotechnologyPharmaceutical
Series AOct 14, 2022
Amount Raised: $30,136,645
AstriVax

Heverlee, Vlaams-Brabant, Belgium

AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.

Clinical TrialsMedical
SeedAug 25, 2022
Amount Raised: $29,912,416
Cairdac

Antony, Ile-de-France, France

Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.

Health CareManufacturingMedical Device
Series AMar 31, 2022
Amount Raised: $18,825,802
SeqOne Genomics

Montpellier, Languedoc-Roussillon, France

SeqOne is a next generation genomic analysis for next generation healthcare.

AnalyticsBig DataBiotechnologyHealth Care
Series AJan 24, 2022
Amount Raised: $22,647,005